These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9140992)

  • 1. TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions.
    Kitamura M; Sütö TS
    Nephrol Dial Transplant; 1997 Apr; 12(4):669-79. PubMed ID: 9140992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transforming growth factor-beta: a new approach to the pathogenesis of glomerulonephritis and glomerulosclerosis].
    Witowski J; Knapowski J
    Przegl Lek; 1995; 52(9):467-73. PubMed ID: 8834649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for TGF-beta-mediated 'defense' of the glomerulus: a blackguard molecule rehabilitated?
    Kitamura M; Fine LG
    Exp Nephrol; 1998; 6(1):1-6. PubMed ID: 9523166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta and the pathogenesis of glomerular diseases.
    Border WA
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):54-8. PubMed ID: 7850412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of TGF-beta in glomerular diseases].
    Okuda S
    Nihon Rinsho; 1992 Dec; 50(12):3032-7. PubMed ID: 1491456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine networks and the pathogenesis of glomerulonephritis.
    Johnson RJ
    J Lab Clin Med; 1993 Feb; 121(2):190-2. PubMed ID: 8433031
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of platelet-derived growth factor in progression of nephropathy].
    Spustová V; Oksa A; Dzúrik R
    Vnitr Lek; 1996 Dec; 42(12):842-8. PubMed ID: 9072884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glomerulonephritis and cytokines].
    Koide H
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):183-93. PubMed ID: 7910863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis.
    Okuda S; Nakamura T; Yamamoto T; Ruoslahti E; Border WA
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9765-9. PubMed ID: 1946401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMP-534 inhibits TGF-beta-induced ECM production in fibroblast cells and reduces mesangial matrix accumulation in experimental glomerulonephritis.
    Sugaru E; Sakai M; Horigome K; Tokunaga T; Kitoh M; Hume WE; Nagata R; Nakagawa T; Taiji M
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F998-1004. PubMed ID: 15900023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of glomerular injury. Glomerular crescent formation.
    Holzman LB; Wiggins RC
    Semin Nephrol; 1991 May; 11(3):346-53. PubMed ID: 2057647
    [No Abstract]   [Full Text] [Related]  

  • 12. Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis.
    Peters H; Border WA; Noble NA
    Kidney Int; 2000 Mar; 57(3):992-1001. PubMed ID: 10720952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and myofibroblast expression in human glomerular disease: a possible link with transforming growth factor-beta-1.
    Goumenos DS; Tsamandas AC; El Nahas AM; Thomas G; Tsakas S; Sotsiou F; Bonikos DS; Vlachojannis JG
    Nephron; 2002 Oct; 92(2):287-96. PubMed ID: 12218305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.
    Kopp JB; Factor VM; Mozes M; Nagy P; Sanderson N; Böttinger EP; Klotman PE; Thorgeirsson SS
    Lab Invest; 1996 Jun; 74(6):991-1003. PubMed ID: 8667617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis.
    Kagami S; Border WA; Ruoslahti E; Noble NA
    Lab Invest; 1993 Jul; 69(1):68-76. PubMed ID: 8331901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological changes and immunohistochemical markers in the assessment of glomerulosclerosis in patients with glomerulonephritis.
    Bob FR; Gluhovschi G; Herman D; Bozdog G; Gluhovschi C; Velciov S; Potencz E; Petrica L
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1027-32. PubMed ID: 22119820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology.
    Bruijn JA; Roos A; de Geus B; de Heer E
    J Lab Clin Med; 1994 Jan; 123(1):34-47. PubMed ID: 8288959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytokines in inflammatory glomerular injury.
    Lakkis FG; Coêlho SN
    Miner Electrolyte Metab; 1995; 21(4-5):250-61. PubMed ID: 7565474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of TGF-beta 1 in experimental glomerulonephritis.
    Border WA; Okuda S; Nakamura T; Languino LR; Ruoslahti E
    Ciba Found Symp; 1991; 157():178-89; discussion 189-93. PubMed ID: 2070683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo transfer of engineered macrophages into the glomerulus: endogenous TGF-beta-mediated defense against macrophage-induced glomerular cell activation.
    Sütö TS; Fine LG; Shimizu F; Kitamura M
    J Immunol; 1997 Sep; 159(5):2476-83. PubMed ID: 9278341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.